Equities

Medinotec Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MDNC:QXR

Medinotec Inc

Actions
  • Price (USD)5.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Apr 14 2025.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medinotec Inc., through its primary investment in DISA Medinotec Proprietary Limited, is engaged in medical device manufacturing and distribution. The Company’s segments include Sales Outside the United States and Domestic Sales. The Sales Outside the United States segment includes both internally developed products and third-party products distributed under agreement. The Domestic Sales segment focuses on the proprietary Trachealator product within the United States. The Company manufactures and distributes medical devices that focus on tracheal non-occlusive airway dilatation technology. Its products include Trachealator, Cape Cross PTCA Catheter, Cape Cross Non-Compliant Catheter, Aortic Valve Dilatation Balloon Catheter, and Micro CTO Catheter. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.

  • Revenue in USD (TTM)11.43m
  • Net income in USD2.34m
  • Incorporated2021
  • Employees51.00
  • Location
    Medinotec IncNorthlands Deco Park,10 New Market Street, Stand 299 Avant GaJOHANNESBURG 2169South AfricaZAF
  • Phone+27 873302301
  • Websitehttps://www.medinotecinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Spectral AI Inc23.17m-16.37m46.65m78.00------2.01-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Heartbeam Inc0.00-20.62m48.22m16.00--118.42-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
electroCore, Inc.29.84m-14.16m49.09m73.00------1.65-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Sharps Technology Inc2.51m-104.37m51.61m5.00--0.1135--20.55-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Nutriband Inc2.28m-34.59m52.05m13.00--6.89--22.84-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Alpha Pro Tech Ltd59.10m3.68m52.21m130.0014.760.828811.590.88360.34150.34155.466.080.8031.6410.62454,584.605.0013.855.2314.5838.2140.646.2312.787.70--0.000.00-5.544.39-6.215.5424.04--
Neuraxis Inc3.36m-8.37m57.42m21.00--23.36--17.08-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
CS Diagnostics Corp0.00-341.62k57.50m5.00---------531,454.00-531,454.00----0.00-------579.61-1,264.84-----------209,220.50------------32.83------
Accuray Inc436.97m-35.62m57.60m990.00--1.08--0.1318-0.2982-0.29823.890.47130.94342.105.90441,382.80-7.69-1.60-13.56-2.7227.8335.04-8.15-1.750.7091-0.38320.7178--2.683.6789.77--2.76--
Medinotec Inc11.43m2.34m58.78m51.0025.0810.6924.695.140.19940.19940.97340.46791.874.047.03224,166.5038.33--49.87--58.25--20.48--3.8937.940.00008--81.53--633.61------
Positron Corp1.24m-1.27m59.04m22.00------47.73-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Outset Medical Inc119.48m-81.65m59.51m310.00--0.4651--0.4981-6.78-6.787.876.990.44231.363.74385,406.40-30.23-37.90-35.71-43.8239.1324.03-68.34-116.475.40-10.190.4312--5.0919.0636.20---38.55--
Pulmonx Corp91.66m-56.75m61.46m291.00--1.02--0.6705-1.41-1.412.281.460.59971.477.20314,996.60-37.13-26.27-42.91-28.9673.3072.91-61.91-89.484.15--0.3821--22.0120.787.31--14.98--
Sensus Healthcare Inc35.61m-3.01m63.06m35.00--1.23--1.77-0.1847-0.18472.183.110.60281.322.711,017,400.00-5.0913.01-5.6614.9847.9561.32-8.4419.455.27--0.00--71.318.931,270.52---7.18--
Forian Inc28.11m-852.58k65.25m1.00--2.09--2.32-0.0274-0.02740.90241.000.5692--4.4628,106,910.00-1.73-24.90-2.92-29.2355.4071.84-3.03-67.83----0.00---5.015.68-257.42------
QT Imaging Holdings Inc11.50m-19.51m67.68m20.00------5.89-2.09-2.091.27-0.9391.201.346.57574,821.50-204.52---4,313.85--50.81---169.73--0.4745-2.0280.26--11,987.88---132.34------
Data as of Apr 14 2025. Currency figures normalised to Medinotec Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.